Aarhus University Seal

MIND

  • A Lundbeck Foundation Research Center

Events

No upcoming events.

Research Groups

Associated Groups

Recent publications

Brikell, I., Astrup, A., Wimberley, T., Araki, M., Chang, Z., Demontis, D., Dong, Z., Faraone, S. V., Gao, L., Gillies, M. B., Haavik, J., Hartman, C., Larsson, H., Man, K. K. C., Pearson, S. A., Snieder, H., Vos, M., Wong, I. C. K., Yao, H. ... Klungsøyr, K. (2026). Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study. BMJ Mental Health, 29(1), Article e302469. https://doi.org/10.1136/bmjment-2025-302469
Starnawska, A., Nielsen, T. T., Grove, J., Cordero-Solorzano, J., Bybjerg-Grauholm, J., Psychiatric Genomics Consortium Autism Spectrum Disorder Working Group, Corfield, E. C., Anney, R. J. L., Docherty, A. R., Børglum, A. D. & Demontis, D. (2026). Genetic architecture and risk of suicide attempt across neurodevelopmental and psychiatric conditions. Biological Psychiatry. Advance online publication. https://doi.org/10.1016/j.biopsych.2026.09.028
Klem, L., Dumas, D., Swift, I. J., Frandsen, S. L., Mikkelsen, D. N., Fensbaek, L., Yavuz, Y., Merton, O., Castricum, J., Prichardt, S., Wynne, G. M., Riisager, A., Schultz, N., Little, P. B., Pedersen, O., Thijssen, E., Nykjaer, A., Kremer, P. & Kjolby, M. (2026). Preclinical and clinical investigation of VES001, an oral small molecule sortilin receptor inhibitor for the treatment of frontotemporal dementia: a first-in-human randomized placebo-controlled phase 1 trial. Nature Communications , 17(1), Article 10804. https://doi.org/10.1038/s41467-026-77638-2